#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12004	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2175	549.0	0	.	n	.	0	T536C	SNP	536	536	T	827	827	C	693	C,T	647,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12004	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2175	549.0	0	.	n	.	0	T1157C	SNP	1157	1157	T	1448	1448	C	708	C,T,G	589,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12004	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2175	549.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1741	1741	T	616	T	574	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12004	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2175	549.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1475	1475	C	783	C,T	725,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12004	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2175	549.0	0	HET	.	.	.	A337G	.	337	337	A	628	628	A	657	A,G	426,187	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12004	16S	1529	1529	99.8	16S.l15.c17.ctg.1	2175	549.0	0	HET	.	.	.	C321T	.	321	321	C	612	612	C	630	C,T	421,161	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21774	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3511	617.9	0	.	n	.	0	C1623T	SNP	1623	1623	C	1996	1996	T	653	T,C,G	580,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21774	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3511	617.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2344	2344	C	677	C	622	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21774	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3511	617.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2418	2418	A	693	A	654	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21774	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3511	617.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2970	2970	C	655	C,A	624,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	8	blaTEM	861	120	100.0	blaTEM.l15.c4.ctg.1	159	2.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1562	folP	855	855	100.0	folP.l15.c17.ctg.1	1444	107.1	1	SNP	p	R229S	1	.	.	685	687	AGC	913	915	AGC	176;173;174	A;G;C	163;159;160	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4204	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3331	125.7	1	SNP	p	S91F	1	.	.	271	273	TTC	576	578	TTC	143;143;144	T;T;C	137;134;136	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4204	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3331	125.7	1	SNP	p	D95G	1	.	.	283	285	GGC	588	590	GGC	132;128;128	G;G;C	127;122;121	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4204	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3331	125.7	1	SNP	p	G95N	0	.	.	283	285	GGC	588	590	GGC	132;128;128	G;G;C	127;122;121	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1368	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1400	97.3	1	SNP	p	G45D	1	.	.	133	135	GAC	476	478	GAC	158;160;161	G;A;C	152;151;152	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	734	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1039	70.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	3754	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.3	1	SNP	p	D86N	0	.	.	256	258	GAC	531	533	GAC	167;164;165	G;A;C	163;156;161	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	3754	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.3	1	SNP	p	S87I	0	.	.	259	261	AGT	534	536	AGT	164;161;162	A;G;T	157;157;156	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	3754	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.3	1	SNP	p	S87W	0	.	.	259	261	AGT	534	536	AGT	164;161;162	A;G;T	157;157;156	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	3754	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.3	1	SNP	p	S87R	0	.	.	259	261	AGT	534	536	AGT	164;161;162	A;G;T	157;157;156	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	3754	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2895	129.3	1	SNP	p	S88P	0	.	.	262	264	TCC	537	539	TCC	161;166;166	T;C;C	154;159;159	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3488	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2535	136.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1472	1474	GGC	153;150;149	G;G;C	142;136;135	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1232	1234	GCA	205;203;202	G;C;A	188;189;191	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1235	1237	ATC	203;201;200	A;T;C	191;190;191	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1247	1249	GTG	194;196;196	G;T;G	182;184;182	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1247	1249	GTG	194;196;196	G;T;G	182;184;182	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1751	1753	ACC	173;173;171	A;C;C	164;166;163	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1805	1807	GCG	147;147;149	G;C;G	132;123;132	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1805	1807	GCG	147;147;149	G;C;G	132;123;132	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1928	1930	GGT	129;127;132	G;G;T	117;118;121	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1937	1939	GGC	129;129;128	G;G;C	119;118;117	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3442	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2356	145.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1955	1957	CCG	132;133;133	C;C;G	102;119;101	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	4734	ponA	2397	2397	99.83	ponA.l15.c17.ctg.1	3070	153.6	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1507	1509	ACG	186;187;190	A,G;C;G,A	168,1;173;177,1	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	4734	ponA	2397	2397	99.83	ponA.l15.c17.ctg.1	3070	153.6	0	.	p	.	0	A471T	NONSYN	1411	1413	GCA	1795	1797	ACA	180;178;176	A,G;C;A	159,2;161;160	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	4734	ponA	2397	2397	99.83	ponA.l15.c17.ctg.1	3070	153.6	0	.	p	.	0	T692M	NONSYN	2074	2076	ACG	2458	2460	ATG	175;174;176	A;T;G	148;152;156	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	4734	ponA	2397	2397	99.83	ponA.l15.c17.ctg.1	3070	153.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1645	1647	CTG	150;151;152	C;T;G	137;135;138	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1642	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1748	93.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	511	511	C	128	C	120	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2452	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1495	162.6	0	.	p	.	0	R143G	NONSYN	427	429	AGA	741	743	GGA	203;203;203	G,C;G,A;A	188,1;189,1;187	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2452	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1495	162.6	0	.	p	.	0	.	INDELS	629	630	AA	944	946	TAG	201;201;199	T;A;G,T	189;191;184,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2452	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1495	162.6	0	.	p	.	0	.	MULTIPLE	631	633	TAC	948	951	CAAT	199;200;204;201	C;A;A;T	187;192;195;191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2452	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1495	162.6	0	.	p	.	0	N212fs	FSHIFT	634	634	A	953	953	T	198	T	192	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2452	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1495	162.6	1	SNP	p	G120K	0	.	.	358	360	GGT	672	674	GGT	182;181;181	G;G;T,C	170;167;163,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2452	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1495	162.6	1	SNP	p	A121D	0	.	.	361	363	GCC	675	677	GCC	184;184;188	G;C;C	173;173;177	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2452	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1495	162.6	1	SNP	p	A121N	0	.	.	361	363	GCC	675	677	GCC	184;184;188	G;C;C	173;173;177	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9512	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4899	193.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2062	2064	CAT	227;227;226	C,A;A;T	214,1;214;214	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1108	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	831	130.8	1	SNP	p	V57M	1	.	.	169	171	ATG	426	428	ATG	220;218;218	A;T;G	209;205;206	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	8104	tetM	1920	1920	100.0	tetM.l15.c30.ctg.1	2527	319.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
